News for LEVITEE LABS INC (LVTTF)

Akanda Corp. (NASDAQ: AKAN) announced its subsidiary Canmart Ltd. brought Tejinder Virk’s service agreement dated June 2, 2021 to an immediate end with effect from February 13th, 2023.

International medical cannabis platform company Akanda Corp. today announced its subsidiary Canmart Ltd. brought Tejinder Virk’s Service Agreement dated June 2, 2021 to an immediate end with... | February 16, 2023

Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. ... | February 6, 2023

Read Levitee Labs Inc. (OTCMKTS:LVTTF) Short Interest Update at ETF Daily News

Read Levitee Labs Inc. (OTCMKTS:LVTTF) Sees Significant Growth in Short Interest at ETF Daily News

Read Short Interest in Levitee Labs Inc. (OTCMKTS:LVTTF) Rises By 45.5% at ETF Daily News

Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) (the "Company" or "Levitee") is pleased to announce the Company has appointed Dave Jenkins as interim CFO following the resignation of Maigul Wickham. The Company would like to thank Ms. Wickham for her efforts and wishes her well in her future en...

VANCOUVER, British Columbia, Feb. 01, 2022 (GLOBE NEWSWIRE) — Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) (the “ Company ” or “ Levitee ”) is…

Wellness company Levitee Labs Inc. (CSE:LVT) (OTC:

The agreement is anticipated to contribute to correcting the opioid crisis in Canada and serve as a foundation for both companies to potentially expand into…

VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) — In a press release issued earlier today under the same headline by Levitee Labs Inc. (CSE: LVT)…

Signed LOI to acquire 100% interest in chain of specialty addiction pharmacies in Vancouver, BC Acquisition price of $4.0 million based upon approximately

Levitee Labs achieves combined September 2021 and October 2021 revenues of $1,553,728 Consistent revenue growth and acquisitions across core divisions of ...

Levitee Labs acquiring 51% interest in new R&D compounding pharmacy in Calgary, Alberta, Canada New pharmacy to focus on production of intranasal ketamine

Levitee Labs will be a Gold Sponsor and VIP Lounge Sponsor at the world's largest psychedelic medicine conference If you would like to attend either of